search
Back to results

Use of Hair to Diagnose the Presence of Breast Cancer

Primary Purpose

Breast Cancer

Status
Unknown status
Phase
Phase 1
Locations
Australia
Study Type
Interventional
Intervention
diagnosis of breast cancer by x-ray diffraction of hair
Sponsored by
Fermiscan Ltd
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional screening trial for Breast Cancer focused on measuring breast cancer, diagnosis, x-ray diffraction, synchrotron, hair

Eligibility Criteria

20 Years - undefined (Adult, Older Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria:

  • Adult women (aged >20) who are undergoing mammography, and
  • Who are willing and able to provide informed consent; and
  • Who have usable scalp and/or pubic hair

Exclusion Criteria:

  • Women who have dyed or permed their scalp hair within the previous 6 weeks and whose pubic hair is unavailable;
  • Women with a history of breast cancer ever or other cancers (excluding non-melanoma skin cancer and CIN [cervical intra-epithelial neoplasia]) within 5 years.

Sites / Locations

  • Bankstown Diagnostic Imaging CentreRecruiting
  • Campbelltown Ultrascan RadiologyRecruiting
  • Diagnostic Imaging Centre, St George Private HospitalRecruiting
  • Liverpool Ultrascan RadiologyRecruiting
  • Penrith ImagingRecruiting

Outcomes

Primary Outcome Measures

Accuracy (sensitivity and specificity) of the breast cancer test based on detection of an abnormal pattern of hair x-ray diffraction compared to the gold standard of mammography plus biopsy where indicated

Secondary Outcome Measures

The prevalence of a positive hair x-ray diffraction pattern and a negative mammogram; and the prevalence of a negative hair x-ray diffraction pattern and a positive mammogram;

Full Information

First Posted
January 7, 2007
Last Updated
January 7, 2007
Sponsor
Fermiscan Ltd
search

1. Study Identification

Unique Protocol Identification Number
NCT00419900
Brief Title
Use of Hair to Diagnose the Presence of Breast Cancer
Study Type
Interventional

2. Study Status

Record Verification Date
January 2007
Overall Recruitment Status
Unknown status
Study Start Date
December 2006 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
undefined (undefined)

3. Sponsor/Collaborators

Name of the Sponsor
Fermiscan Ltd

4. Oversight

5. Study Description

Brief Summary
Using synchrotron X-ray diffraction, it has been reported that a hair from an individual with breast cancer exhibits a difference in its molecular structure compared to that of an individual without breast cancer. This difference is visible in the X-ray diffraction pattern as a ring superimposed on the pattern for normal hair. The hypothesis of this study is that synchrotron x-ray diffraction can be used to differentiate hairs from women with medically diagnosed breast cancer from women not known to have the disease. To test this hypothesis, hair from 2000 women attending radiology clinics for mammography will be collected, analysed by x-ray diffraction and then analysed using Fermiscan proprietary image analysis software. The mammogram status of the subjects will be blinded from the diffraction analysts. Results will then be compared with mammography results to allow a direct comparison between the Fermiscan test and mammography in terms of specificity and sensitivity.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Breast Cancer
Keywords
breast cancer, diagnosis, x-ray diffraction, synchrotron, hair

7. Study Design

Primary Purpose
Screening
Study Phase
Phase 1, Phase 2
Interventional Study Model
Single Group Assignment
Masking
Single
Allocation
Randomized
Enrollment
2000 (false)

8. Arms, Groups, and Interventions

Intervention Type
Procedure
Intervention Name(s)
diagnosis of breast cancer by x-ray diffraction of hair
Primary Outcome Measure Information:
Title
Accuracy (sensitivity and specificity) of the breast cancer test based on detection of an abnormal pattern of hair x-ray diffraction compared to the gold standard of mammography plus biopsy where indicated
Secondary Outcome Measure Information:
Title
The prevalence of a positive hair x-ray diffraction pattern and a negative mammogram; and the prevalence of a negative hair x-ray diffraction pattern and a positive mammogram;

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
20 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Adult women (aged >20) who are undergoing mammography, and Who are willing and able to provide informed consent; and Who have usable scalp and/or pubic hair Exclusion Criteria: Women who have dyed or permed their scalp hair within the previous 6 weeks and whose pubic hair is unavailable; Women with a history of breast cancer ever or other cancers (excluding non-melanoma skin cancer and CIN [cervical intra-epithelial neoplasia]) within 5 years.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Peter W French, BSc, MSc, PhD
Phone
+61292454460
Email
pfrench@fermiscan.com.au
First Name & Middle Initial & Last Name or Official Title & Degree
Gary Corino, BSc
Phone
+61292454460
Email
gcorino@fermiscan.com.au
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Phillip Yuile, MBBS, FRACR
Organizational Affiliation
Radiation Oncology Associates, Sydney, Australia
Official's Role
Principal Investigator
Facility Information:
Facility Name
Bankstown Diagnostic Imaging Centre
City
Sydney
State/Province
New South Wales
ZIP/Postal Code
2200
Country
Australia
Individual Site Status
Recruiting
Facility Name
Campbelltown Ultrascan Radiology
City
Sydney
State/Province
New South Wales
Country
Australia
Individual Site Status
Recruiting
Facility Name
Diagnostic Imaging Centre, St George Private Hospital
City
Sydney
State/Province
New South Wales
Country
Australia
Individual Site Status
Recruiting
Facility Name
Liverpool Ultrascan Radiology
City
Sydney
State/Province
New South Wales
Country
Australia
Individual Site Status
Recruiting
Facility Name
Penrith Imaging
City
Sydney
State/Province
New South Wales
Country
Australia
Individual Site Status
Recruiting

12. IPD Sharing Statement

Citations:
PubMed Identifier
16876335
Citation
James VJ. A place for fiber diffraction in the detection of breast cancer? Cancer Detect Prev. 2006;30(3):233-8. doi: 10.1016/j.cdp.2006.04.001. Epub 2006 Jul 28.
Results Reference
background
PubMed Identifier
15645416
Citation
James V, Corino G, Robertson T, Dutton N, Halas D, Boyd A, Bentel J, Papadimitriou J. Early diagnosis of breast cancer by hair diffraction. Int J Cancer. 2005 May 10;114(6):969-72. doi: 10.1002/ijc.20824.
Results Reference
background
PubMed Identifier
12529353
Citation
James V. False-positive results in studies of changes in fiber diffraction of hair from patients with breast cancer may not be false. J Natl Cancer Inst. 2003 Jan 15;95(2):170-1. doi: 10.1093/jnci/95.2.170. No abstract available. Erratum In: J Natl Cancer Inst. 2003 Feb 19;95(4):334.
Results Reference
background
PubMed Identifier
11390537
Citation
Meyer P, James VJ. Experimental confirmation of a distinctive diffraction pattern in hair from women with breast cancer. J Natl Cancer Inst. 2001 Jun 6;93(11):873-5. doi: 10.1093/jnci/93.11.873. No abstract available.
Results Reference
background
PubMed Identifier
10078527
Citation
James V, Kearsley J, Irving T, Amemiya Y, Cookson D. Using hair to screen for breast cancer. Nature. 1999 Mar 4;398(6722):33-4. doi: 10.1038/17949. No abstract available.
Results Reference
background

Learn more about this trial

Use of Hair to Diagnose the Presence of Breast Cancer

We'll reach out to this number within 24 hrs